1.Change in Facial Skin Quality after Consuming a Collagen Containing Beverage
Mayu ITO ; Mika MIKI ; Hirotaka HAYASHI ; Takanari ARAI ; Nobutaka SUZUKI ; Kazuo UEBABA
Japanese Journal of Complementary and Alternative Medicine 2009;6(2):111-118
We conducted a preliminary study of the facial skin-improving effects of collagen-containing beverages as evaluated by objective indices. After obtaining written informed consent, 61 healthy females (age: 25–68, 34±8 y.o.) were randomly divided into two groups, receiving beverages containing 5 g (N=30) and 10 g (N=31), respectively, of collagen daily for one month. Facial skin moisture content and lower eyelid wrinkles were assessed before, 1 week and 1 month after consuming the test beverages. Results were analyzed of the 5 g and 10 g groups, as well as responder and non-responder groups. 10 g collagen beverages showed 50% effectiveness, and were more effective than the 5 g beverage; the effect was observable within 1 week. Furthermore, subjects with more wrinkles and drier skin showed greater benefit than those with higher facial skin moisture content and/or fewer wrinkles. It is suggested that a beverage containing 10 g collagen should be used for aged subjects with more wrinkles and/or drier skin for a period of 1–2 months in future randomized placebo-controlled trials of collagen-containing beverages.
2.Effect of tramadol on cancer pain in a patient with advanced endometrial carcinoma and myasthenia gravis: a case report
Yoshihiro Yamamoto ; Maki Todo ; Kikuyo Nishida ; Keita Iwasaki ; Chiharu Suzuki ; Miki Kondo ; Shoko Kinoshita ; Kazuyo Kanbara ; Hiromitsu Yabushita ; Akihiko Wakatsuki ; Katsuhiko Matsuura ; Mari Nishihara ; Kenichi Arai
Palliative Care Research 2013;8(2):570-574
Introduction: Tramadol (TRM) has been included as a weak opioid at the second step of the WHO analgesic ladder and has been widely used in palliative medicine. Here we report a case of amelioration of cancer pain by TRM therapy in a female patient with myasthenia gravis (MG). Case:The patient was a 70’s woman who was diagnosed with advanced endometrial carcinoma and suffered from chest pain caused by chest metastasis. 25 mg of a TRM capsule was orally administered three times a day. The dose was increased to 50 mg twice a day. It was resulted in sound pain relief with transient muscle weakness but without a myasthenic crisis.
3.A Case of a Meningeal Carcinomatosis of the Internal Auditory Meatus Treated as Sudden Deafness
Fumiyuki GOTO ; Miki ARAI ; Takeshi WAKABAYASHI ; Tomoko OTOMO ; Ryoto NAGAI ; Shuujiro MINAMI ; Takanobu SHIMADA ; Masato FUJII
Journal of the Korean Balance Society 2015;14(4):139-142
We describe a case of meningeal carcinomatosis of the internal auditory meatus presenting as sudden deafness accompanied by dizziness. A 54-year-old woman complained of acute right-side hearing loss in October 2014. The pure tone audiometry test revealed right-side hearing loss of 47.5 dB. She was treated with oral steroids. Her hearing as well as her symptoms of dizziness worsened and she was admitted for further examination. Her right and left-side hearing had worsened to 105.0 dB and 47.5 dB, respectively. A magnetic resonance imaging scan of the head revealed bilateral enhancement of the internal auditory canal and multiple brain metastases. The chest radiograph revealed a mass in the left lung. Adenocarcinoma of the lung was diagnosed. Lumbar puncture yielded no evidence of carcinoma cells in the cerebrospinal fluid, but an increased number of lymphocytes was confirmed. A diagnosis of multiple brain metastases and leptomeningeal metastasis from the adenocarcinoma of the lung was considered. Whole-brain radiation therapy (30 Gr/10 fractions) was administered. Progressive bilateral hearing loss is a rare first manifestation of meningeal carcinomatosis. It is quite important to consider the possibility of this condition when patients present with sudden deafness.
Adenocarcinoma
;
Audiometry
;
Brain
;
Cerebrospinal Fluid
;
Diagnosis
;
Dizziness
;
Ear, Inner
;
Female
;
Head
;
Hearing
;
Hearing Loss
;
Hearing Loss, Bilateral
;
Hearing Loss, Sudden
;
Humans
;
Lung
;
Lymphocytes
;
Magnetic Resonance Imaging
;
Meningeal Carcinomatosis
;
Middle Aged
;
Neoplasm Metastasis
;
Radiography, Thoracic
;
Spinal Puncture
;
Steroids
;
Temporal Bone
4.Genomic Basis for Methicillin Resistance in Staphylococcus aureus.
Keiichi HIRAMATSU ; Teruyo ITO ; Sae TSUBAKISHITA ; Takashi SASAKI ; Fumihiko TAKEUCHI ; Yuh MORIMOTO ; Yuki KATAYAMA ; Miki MATSUO ; Kyoko KUWAHARA-ARAI ; Tomomi HISHINUMA ; Tadashi BABA
Infection and Chemotherapy 2013;45(2):117-136
Since the discovery of the first strain in 1961 in England, MRSA, the most notorious multidrug-resistant hospital pathogen, has spread all over the world. MRSA repeatedly turned down the challenges by number of chemotherapeutics, the fruits of modern organic chemistry. Now, we are in short of effective therapeutic agents against MRSA prevailing among immuno-compromised patients in the hospital. On top of this, we recently became aware of the rise of diverse clones of MRSA, some of which have increased pathogenic potential compared to the classical hospital-associated MRSA, and the others from veterinary sources. They increased rapidly in the community, and started menacing otherwise healthy individuals by causing unexpected acute infection. This review is intended to provide a whole picture of MRSA based on its genetic makeup as a versatile pathogen and our tenacious colonizer.
Adenosine
;
Chemistry, Organic
;
Chromatography, Micellar Electrokinetic Capillary
;
Clone Cells
;
Colon
;
England
;
Fruit
;
Humans
;
Methicillin
;
Methicillin Resistance
;
Methicillin-Resistant Staphylococcus aureus
;
Sprains and Strains
;
Staphylococcus
;
Staphylococcus aureus